The Journal of Clinical Endocrinology & Metabolism · 2007 · 41 citations · 25 references
MedicineEndocrinologyEndocrine PharmacotherapyHormone BiochemistryMineral MetabolismGrowth HormoneGrowth Hormone TherapyHormone MetabolismThyroid Axis RegulationThyroid DisordersThyroid EndocrinologyBasal Energy ExpenditureEnergy Expenditure AlterationGrowth Hormone Replacement TherapySerum Thyroid-stimulating Hormone MeasurementThyroid Function EvaluationThyroid Hormone PhysiologyThyroid Hormone Replacement TherapyThyroxine Biosynthesis
CONTEXT: The biological significance of GH-induced changes in serum TH concentrations is unknown. It has been suggested that serum free T(4) (FT(4)) should be targeted at the high-normal range during GH replacement. OBJECTIVE: Our objective was to evaluate the effects of GH replacement on T(4) biological effects. HYPOTHESIS: If GH modulates thyroxine biological effects, serum FT(4) should be targeted accordingly. DESIGN AND SETTING: We conducted observational (study 1) and interventional (studies 2 and 3)/outpatient studies. PATIENTS: Thirty-two GH-deficient patients (13 off GH; 22 on l-T(4)) participated in the study. INTERVENTIONS: In study 2, levothyroxine was administered to increase FT(4) (>1.0 ng/dl). In study 3, GH was administered or withdrawn. MAIN OUTCOME MEASURES: We measured FT(4), total T(3) (TT(3)), myocardial isovolumic contraction time (ICT), and resting energy expenditure (REE). RESULTS: In study 1, off-GH and on-GH groups had similar FT(4), but off GH showed lower TT(3) (P < 0.01) and REE (P = 0.02), higher ICT (P < 0.05) than on-GH and controls. On GH, ICT and REE correlated only with TT(3) (r = -0.48; r = 0.58; P < 0.05). Off GH, ICT correlated only with FT(4) (P < 0.01). In study 2, off GH, levothyroxine intervention increased FT(4) (P = 0.005) and TT(3) (P = 0.012), decreased ICT (P = 0.006), and increased REE (P = 0.013); ICT and FT(4) changes correlated (r = -0.72; P = 0.06). On GH, levothyroxine increased FT(4) (P = 0.0002), TT(3) (P = 0.014), and REE (P = 0.10) and decreased ICT (P = 0.049); REE and TT(3) changes correlated (r = 0.60; P = 0.05). In study 3, GH decreased FT(4), increased TT(3), decreased ICT, and increased REE (P < 0.05). REE correlated (P < 0.05) with IGF-I (r = 0.57) and TT(3) (r = 0.64). ICT correlated only with TT(3) (r = -0.46). CONCLUSIONS: GH replacement improves the biological effects of T(4). Serum FT(4) should be targeted at the high-normal range in GH-deficient patients only off GH replacement.
25
Stig Andersen, Klaus M. Pedersen, Niels Henrik Bruun et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 648 citations · Full text
Manfred J. Müller, Anja Bosy‐Westphal, Susanne Klaus et al. · American Journal of Clinical Nutrition · 2004 · 348 citations · Full text
Hana Al-Adsani, L. John Hoffer, J. Enrique Silva · The Journal of Clinical Endocrinology & Metabolism · 1997 · 239 citations · Full text
Noninvasive Evaluation of Cardiac Function in Hypothyroidism
William F. Crowley, E. Chester Ridgway, Edward W. Bough et al. · New England Journal of Medicine · 1977 · 239 citations
Medicine, Cardiology, Endocrinology +15